Novavax (NVAX) Stock Surges YTD as COVID Vaccine Advances Well Posted byZacks Equity Research September 13, 2021 Leave a comment on Novavax (NVAX) Stock Surges YTD as COVID Vaccine Advances Well Upon approval and successful commercialization, Novavax’s (NVAX) COVID-19 vaccine should reap huge revenues. The company’s other pipeline candidates a…